Skip to content

Perioperative study of quality of life and body composition in pancreatic cancer – a prospective observational trial

Perioperative study of quality of life and body composition in pancreatic cancer – a prospective observational trial - BoCoPanc

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00034209
Enrollment
200
Registered
2024-06-24
Start date
2025-01-08
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C25

Interventions

Group 1: Patients with clinical stage I-III resectable and borderline resectable pancreatic cancer (PDAC) scheduled for curative intent surgical resection

Sponsors

Universitätsklinikum Schleswig Holstein Campus Lübeck
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Age at least 18 years old and capable of signing informed consent - Patient deemed fit to undergo curative intent surgery and perioperative therapy - Indication for curative intent PDAC resection according to the German S3 guideline (PDAC histologically proven or CT imaging and further diagnostics (e.g. EUS, MRI, labs) highly suspicious of PDAC) - Resectable PDAC according to the German S3 guideline criteria (CT imaging and biological parameters) - Borderline resectable PDAC according to the German S3 guideline criteria (CT imaging and biological parameters)

Exclusion criteria

Exclusion criteria: - Second malignancy at the time of diagnosis of PDAC - Distant metastasis (M1) - Chemotherapy or radiotherapy already started - Patients with resectable disease who wish to undergo neoadjuvant therapy - Patient does not wish to receive perioperative therapy

Design outcomes

Primary

MeasureTime frame
Body composition parameters (weight, diet, cachexia, motoric status) will be evaluated via CT-based assessment of already existing CT abdomen scans.

Secondary

MeasureTime frame
Patient-reported quality of life (standardized validated questionnaire ED-5D-5L, EORTC-QLQ-C30, EORTC-QLQ-PAN26) in three month intervals after resection

Countries

Germany

Contacts

Public ContactLouisa Bolm

Universitätsklinikum Schleswig-Holstein, Campus Lübeck

louisa.bolm@uksh.de0451-500-40100

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026